###begin article-title 0
Binding site of ABC transporter homology models confirmed by ABCB1 crystal structure
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 250 267 250 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 250 266 <span type="species:ncbi:562">Escherichia coli</span>
The human ATP-binding cassette (ABC) transporters ABCB1, ABCC4 and ABCC5 are involved in resistance to chemotherapeutic agents. Here we present molecular models of ABCB1, ABCC4 and ABCC5 by homology based on a wide open inward-facing conformation of Escherichia coli MsbA, which were constructed in order to elucidate differences in the electrostatic and molecular features of their drug recognition conformations. As a quality assurance of the methodology, the ABCB1 model was compared to an ABCB1 X-ray crystal structure, and with published cross-linking and site directed mutagenesis data of ABCB1. Amino acids Ile306 (TMH5), Ile340 (TMH6), Phe343 (TMH6), Phe728 (TMH7), and Val982 (TMH12), form a putative substrate recognition site in the ABCB1 model, which is confirmed by both the ABCB1 X-ray crystal structure and the site-directed mutagenesis studies. The ABCB1, ABCC4 and ABCC5 models display distinct differences in the electrostatic properties of their drug recognition sites.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 455 456 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 457 458 457 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 616 617 616 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human ATP-binding cassette (ABC) transporters ABCB1, ABCC4 and ABCC5 belong to the ABC superfamily, a subgroup of Primary active transporters [1]. The transporters in the ABC superfamily are structurally related membrane proteins that have a common intracellular motif that exhibits ATPase activity. This motif cleaves ATP's terminal phosphate to energize the transport of molecules from regions of low concentration to regions of high concentration [1-3]. Since ABC genes are highly conserved between species, it is likely that most of these genes have been present since the beginning of eukaryotic evolution [4].
###end p 4
###begin p 5
###xml 152 153 152 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
The overall topology of ABCB1, ABCC4 and ABCC5 is divided into transmembrane domain 1 (TMD1) - nucleotide-binding domain 1 (NBD1) - TMD2 - NBD2 (Figure 1). The Walker A, or phosphate binding loop (P-loop), and Walker B motifs, are localized in the NBDs, while the TMDs contribute to the substrate translocation events (recognition, translocation and release). ABCB1, ABCC4 and ABCC5 are exporters, pumping substrates out of the cell.
###end p 5
###begin p 6
###xml 0 49 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Overall domain topology of ABCB1, ABCC4 and ABCC5</bold>
Overall domain topology of ABCB1, ABCC4 and ABCC5.
###end p 6
###begin p 7
###xml 303 304 303 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 305 306 305 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 357 358 357 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 533 534 533 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
Transporters have drug recognition sites that make them specific for particular substrates, and drugs may interact with these recognition sites and either inhibit the transporter or act as substrates. Experimental studies have shown that ABCB1 transports cationic amphiphilic and lipophilic substrates [5-8], while ABCC4 and ABCC5 transport organic anions [9]. Both ABCC4 and ABCC5 transport cAMP and cGMP, however, with differences in their kinetic parameters; ABCC4 with a preference for cAMP and ABCC5 with a preference for cGMP [9,10].
###end p 7
###begin p 8
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 394 402 394 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 433 441 433 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 519 521 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 889 890 889 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 936 938 936 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 987 989 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 485 489 <span type="species:ncbi:163112">Ling</span>
When chemotherapeutic agents are expelled from cancer cells as substrates of ABCB1, ABCC4 or ABCC5, the result is multidrug resistance. In order to overcome multidrug resistance, development of inhibitors of drug efflux transporters has been sought for use as supplement to drug therapy [11]. However, clinical trials of potential anti-MDR agents have been disappointing due to adverse effects in vivo of agents being very effective in vitro. Even if there is a long time since Victor Ling described MDR, (i.e. ABCB1) [12], very little is known about subtype selective recognition and binding of ABC proteins. Structural insight into their mode of ligand interaction and functional mechanisms will be an important contribution to pinpoint potential drug targets and to design putative inhibitors. Recent papers report a considerable difference in substrate specificity of ABCC4 and ABCC5 [9], including various chemotherapeutic agents [13], and with potential impact on reversal of MDR [14]. Elucidating the molecular aspects of ligand interactions with ABCB1, ABCC4 or ABCC5 may therefore aid in the design of therapeutic agents that can help to overcome multidrug resistance.
###end p 8
###begin p 9
###xml 58 60 58 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 102 124 102 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus </italic>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 340 357 340 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 456 469 456 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 519 521 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 882 884 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1055 1068 1055 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 1075 1077 1075 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1158 1160 1158 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1161 1163 1161 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 102 123 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 340 356 <span type="species:ncbi:562">Escherichia coli</span>
###xml 456 468 <span type="species:ncbi:10090">Mus musculus</span>
###xml 1055 1067 <span type="species:ncbi:10090">Mus musculus</span>
We have previously constructed molecular models of ABCB1 [15], ABCC4 [16] and ABCC5 [17] based on the Staphylococcus aureus ABC transporter Sav1866, which has been crystallized in an outward-facing ATP-bound state [18]. In this study, we present molecular models of ABCB1, ABCC4 and ABCC5 based on a wide open inward-facing conformation of Escherichia coli MsbA [19]. Since the molecular modelling was carried out before the X-ray crystal structure of the Mus musculus ABCB1 in a drug-bound conformation was published [20], we got a unique opportunity to test our methodology, molecular modelling by homology, and the quality of the ABCB1 model, when the crystal structure was published. Since we wanted to elucidate differences in the electrostatic and molecular features of the drug recognition conformation of these transporters, the wide open conformation of the MsbA template [19] was of particular interest. The electrostatic potential surfaces (EPS) of the models were calculated, and the models were compared to the X-ray crystal structure of the Mus musculus ABCB1 [20], and with published cross-linking and site directed mutagenesis data on ABCB1 [21-35].
###end p 9
###begin title 10
Computational methods
###end title 10
###begin title 11
Software
###end title 11
###begin p 12
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
Version 3.4-9b of the Internal Coordinate Mechanics (ICM) program [36] was used for homology modelling, model refinements and electrostatic calculations. The AMBER program package version 8.0 [37] was used for molecular mechanics energy minimization.
###end p 12
###begin title 13
Alignment
###end title 13
###begin p 14
###xml 151 168 151 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 180 196 180 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vibrio cholerae </italic>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 767 769 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 788 790 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 86 91 <span type="species:ncbi:9606">human</span>
###xml 102 107 <span type="species:ncbi:9606">human</span>
###xml 118 123 <span type="species:ncbi:9606">human</span>
###xml 134 139 <span type="species:ncbi:9606">human</span>
###xml 151 167 <span type="species:ncbi:562">Escherichia coli</span>
###xml 180 195 <span type="species:ncbi:666">Vibrio cholerae</span>
A multiple sequence alignment of (SWISS-PROT accession numbers are given in brackets) human ABCB1 (), human ABCC4 (), human ABCC5 (), human ABCC11 (), Escherichia coli MsbA () and Vibrio cholerae MsbA (), obtained using T-COFFEE [38], Version 4.71 available at the Le Centre national de la recherche scientifique website , was used as a basis for the homology modelling module of ICM program [36]. ABCC11 was included in the alignment because it is closely related to ABCC5 phylogenetically [15], and its inclusion may strengthen the alignment. The alignment was adjusted for sporadic gaps in the TMH segments, and for secondary structure predictions defining the boundaries of the TMHs using the PredictProtein server for sequence analysis and structure prediction [39], and SWISS-PROT [40].
###end p 14
###begin p 15
###xml 33 50 33 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 122 139 122 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 473 490 473 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 698 715 698 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 724 726 724 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 863 880 863 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 886 888 886 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 889 891 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 911 928 911 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 1109 1126 1109 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 1132 1134 1132 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1135 1137 1135 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1159 1160 1159 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 17 22 <span type="species:ncbi:9606">human</span>
###xml 33 49 <span type="species:ncbi:562">Escherichia coli</span>
###xml 106 111 <span type="species:ncbi:9606">human</span>
###xml 122 138 <span type="species:ncbi:562">Escherichia coli</span>
###xml 267 274 <span type="species:ncbi:562">E. coli</span>
###xml 355 362 <span type="species:ncbi:562">E. coli</span>
###xml 457 462 <span type="species:ncbi:9606">human</span>
###xml 473 489 <span type="species:ncbi:562">Escherichia coli</span>
###xml 682 687 <span type="species:ncbi:9606">human</span>
###xml 698 714 <span type="species:ncbi:562">Escherichia coli</span>
###xml 847 852 <span type="species:ncbi:9606">human</span>
###xml 863 879 <span type="species:ncbi:562">Escherichia coli</span>
###xml 911 927 <span type="species:ncbi:562">Escherichia coli</span>
###xml 934 939 <span type="species:ncbi:9606">human</span>
###xml 947 952 <span type="species:ncbi:9606">human</span>
###xml 963 968 <span type="species:ncbi:9606">human</span>
###xml 1093 1098 <span type="species:ncbi:9606">human</span>
###xml 1109 1125 <span type="species:ncbi:562">Escherichia coli</span>
The alignment of human ABCB1 and Escherichia coli MsbA was compared to previously published alignments of human ABCB1 and Escherichia coli MsbA [19,41], and it was observed that in our alignment, the ABCB1 sequence was shifted 2 positions to the left relative to the E. coli MsbA sequence in the alignment of TMH2, and 1 position the left relative to the E. coli MsbA sequence in the alignment of TMH6, as compared to the previously published alignments of human ABCB1 and Escherichia coli MsbA [19,41]. Thus, 3 alignments were used to construct 3 ABCB1 models, 1 model with our original alignment, 1 model with TMH2 adjusted to correspond to the previously published alignments of human ABCB1 and Escherichia coli MsbA [19,41], and 1 model with both TMH2 and TMH6 adjusted, thus using the same alignment as the previously published alignments of human ABCB1 and Escherichia coli MsbA [19,41]. The alignment of Escherichia coli MsbA, human ABCB1, human ABCC4 and human ABCC5 used for the homology modelling procedure, with TMH2 adjusted to correspond to the previously published alignments of human ABCB1 and Escherichia coli MsbA [19,41], is shown in Figure 2. For illustrative purposes, only the sequences of the template and the 3 target proteins ABCB1, ABCC4 and ABCC5 are shown.
###end p 15
###begin p 16
###xml 13 30 13 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 0 138 0 138 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Alignment of <italic>Escherichia coli </italic>MsbA, human ABCB1, human ABCC4 and human ABCC5 used as input alignment for the ICM homology modelling module</bold>
###xml 13 29 <span type="species:ncbi:562">Escherichia coli</span>
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 65 70 <span type="species:ncbi:9606">human</span>
Alignment of Escherichia coli MsbA, human ABCB1, human ABCC4 and human ABCC5 used as input alignment for the ICM homology modelling module. TMHs, Walker A motifs and Walker B motifs are indicated as boxes.
###end p 16
###begin title 17
Homology modelling
###end title 17
###begin p 18
###xml 46 63 46 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 468 470 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 46 62 <span type="species:ncbi:562">Escherichia coli</span>
A full atom version of the open inward facing Escherichia coli MsbA X-ray crystal structure (PDB code: [19]) was kindly provided by Geoffery Chang and used as a template in the construction of the homology models of ABCB1, ABCC4 and ABCC5. The ICM program constructs the molecular model by homology from core sections defined by the average of Calpha atom positions in conserved regions. Loops were searched for within several thousand structures in the PDB databank [42] and matched in regard to sequence similarity and sterical interactions with the surroundings of the model, and the best-fitting loop was selected based on calculating the maps around the loops and scoring of their relative energies. The segment connecting NBD1 and TMD2 was also included in the loop search procedure.
###end p 18
###begin title 19
Calculations
###end title 19
###begin p 20
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
The ABCB1, ABCC4 and ABCC5 models were refined by globally optimizing side-chain positions and annealing of the backbone using the RefineModel macro of ICM. The macro was comprised of (1) a side-chain conformational sampling using 'Montecarlo fast' [43], (2) 5 iterative annealings of the backbone with tethers (harmonic restraints pulling an atom in the model to a static point in space represented by a corresponding atom in the template), and (3) a second side-chain conformational sampling using 'Montecarlo fast'. 'Montecarlo fast' samples conformational space of a molecule with the ICM global optimization procedure, and its iterations consist of a random move followed by a local energy minimization, and calculation of the complete energy. The iteration is accepted or rejected based on energy and temperature.
###end p 20
###begin p 21
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
The refined ABCB1, ABCC4 and ABCC5 models were energy minimized using the AMBER 8.0 program package [37]. Two energy minimizations were performed for each model, (1) with restrained backbone by 500 cycles of the steepest descent minimization followed by 500 steps of conjugate gradient minimization, and (2) with no restraints by 1000 cycles of the steepest descent minimization followed by 1500 steps of conjugate gradient minimization. The leaprc.ff03 force field [37], and a 10 A cut-off radius for non-bonded interactions and a dielectric multiplicative constant of 1.0 for the electrostatic interactions, were used in the molecular mechanics calculations.
###end p 21
###begin p 22
The EPS of the ABCB1, ABCC4 and ABCC5 models were calculated with the ICM program, with a potential scale from -10 to +10 kcal/mol.
###end p 22
###begin title 23
Model validation
###end title 23
###begin p 24
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 265 282 265 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 265 281 <span type="species:ncbi:562">Escherichia coli</span>
To check the stereochemical qualities of the ABCB1, ABCC4 and ABCC5 models, the SAVES Metaserver for analyzing and validating protein structures  was used. Programs run were Procheck [44], What_check [45], and Errat [46], and the pdb file of the open inward facing Escherichia coli MsbA template [19] was also checked for comparison with the models.
###end p 24
###begin p 25
###xml 112 125 112 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 112 124 <span type="species:ncbi:10090">Mus musculus</span>
For further validation, the ABCB1, ABCC4 and ABCC5 models were compared with the X-ray crystal structure of the Mus musculus ABCB1 [20] and cross-linking and site directed mutagenesis data published on ABCB1 [21-35].
###end p 25
###begin title 26
Results
###end title 26
###begin p 27
###xml 161 174 161 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 291 308 291 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 498 511 498 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 612 629 612 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 635 637 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 781 783 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 885 898 885 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 905 907 905 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1024 1037 1024 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 1044 1046 1044 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1167 1184 1167 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 1190 1192 1190 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1193 1195 1193 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1246 1248 1246 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1278 1295 1278 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 1419 1420 1419 1420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 161 173 <span type="species:ncbi:10090">Mus musculus</span>
###xml 275 280 <span type="species:ncbi:9606">human</span>
###xml 291 307 <span type="species:ncbi:562">Escherichia coli</span>
###xml 498 510 <span type="species:ncbi:10090">Mus musculus</span>
###xml 596 601 <span type="species:ncbi:9606">human</span>
###xml 612 628 <span type="species:ncbi:562">Escherichia coli</span>
###xml 885 897 <span type="species:ncbi:10090">Mus musculus</span>
###xml 1024 1036 <span type="species:ncbi:10090">Mus musculus</span>
###xml 1151 1156 <span type="species:ncbi:9606">human</span>
###xml 1167 1183 <span type="species:ncbi:562">Escherichia coli</span>
###xml 1278 1294 <span type="species:ncbi:562">Escherichia coli</span>
###xml 1301 1306 <span type="species:ncbi:9606">human</span>
###xml 1330 1335 <span type="species:ncbi:9606">human</span>
###xml 1346 1351 <span type="species:ncbi:9606">human</span>
The 3 ABCB1 models, constructed based on 3 different alignments, where compared with cross-linking data and subsequently also the X-ray crystal structure of the Mus musculus ABCB1 [20], and it was revealed that when TMH2 was aligned as the previously published alignments of human ABCB1 and Escherichia coli MsbA [19,41], amino acids in TMH2/TMH11 (Val133/Gly939 and Cys127/Ala935) where oriented towards each other in accordance with both cross-linking data and the X-ray crystal structure of the Mus musculus ABCB1 [20]. However, when TMH6 was aligned as the previously published alignments of human ABCB1 and Escherichia coli MsbA [19,41], ligand binding amino acids (Ile340 and Phe343) pointed away from the drug binding site, while when aligned as proposed from our T-COFFEE [38] alignment, it was in accordance both with cross-linking data and the X-ray crystal structure of the Mus musculus ABCB1 [20]. Thus, the ABCB1 model which was most in accordance with cross-linking data and the X-ray crystal structure of the Mus musculus ABCB1 [20] was based on the alignment where TMH2 was adjusted according to the previously published alignments of human ABCB1 and Escherichia coli MsbA [19,41], while TMH6 was kept exactly as in our T-COFFEE [38] alignment. The alignment of Escherichia coli MsbA, human ABCB1 (TMH2 adjusted), human ABCC4 and human ABCC5 used for the homology modelling procedure is shown in Figure 2. For illustrative purposes, only the sequences of the template and the 3 target proteins ABCB1, ABCC4 and ABCC5 are shown.
###end p 27
###begin p 28
###xml 72 76 72 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A-C</xref>
###xml 861 863 851 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
The energy minimized ABCB1, ABCC4 and ABCC5 models are shown in Figures 3A-C. Each transporter was in an open V-shaped inward conformation with their NBD1 and NBD2 ~50 A apart. Both Walker A motifs of each model consisted of a coiled loop and a short alpha-helix (P-loop), and the ATP-binding half sites faced each other. The Walker B motifs were in beta-sheet conformation and localized in the NBD's hydrophobic cores, which were constituted of 5 parallel beta-sheets. The amino acids localized on the surface of each NBD were mainly charged. In the "arms" of the V-shaped structure, NBD1 was associated with TMHs 1, 2, 3 and 6 (TMD1), and TMHs 10 and 11 (TMD2), while NBD2 was associated with TMHs 4 and 5 (TMD1), and TMHs 7, 8, 9 and 12 (TMD2). Thus, the TMDs were twisted relative to the NBDs, such that TMH4 and TMH5 were crossed over ("cross-over motif" [19]) and associated with TMD2, and TMH10 and TMH11 were crossed over and associated with TMD1. All TMHs contributed to substrate translocation pore, which was closed towards the extracellular side.
###end p 28
###begin p 29
###xml 0 128 0 124 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Backbone C&#945;-traces of ABCB1 model (A), ABCC4 model (B) and ABCC5 model (C) viewed in the membrane plane, cytoplasm downwards</bold>
Backbone Calpha-traces of ABCB1 model (A), ABCC4 model (B) and ABCC5 model (C) viewed in the membrane plane, cytoplasm downwards. Colour coding: blue via white to red from N-terminal to C-terminal.
###end p 29
###begin p 30
###xml 406 423 399 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 488 490 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 495 497 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 406 422 <span type="species:ncbi:562">Escherichia coli</span>
The loop connecting NBD1 and TMD2 of each transporter was abundant with charged amino acids. The loop connecting NBD1 and TMD2 of ABCB1 was in extended conformation forming a beta-sheet between amino acids sections Lys645-Glu652 and Lys665-Ser671, while the loops connecting the subunits of ABCC4 and ABCC5 were alpha-helical. ABCB5 featured an insertion loop (as compared with the amino acid sequences of Escherichia coli MsbA) from Ile479 to His548 in NBD1, and as displayed in Figures 3C and 4C, this loop was pointing away from NBD1 parallel to the membrane. However, modelling loops of lengths as that of the connection between NBD1 and TMD2 is relatively inaccurate and consequently the modelled loop structures must be regarded as uncertain.
###end p 30
###begin p 31
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A-C</italic>
###xml 0 114 0 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>A-C</italic>: Backbone C&#945;-traces of ABCB1 model (A), ABCC4 model (B) and ABCC5 model (C) viewed from intracellular side</bold>
###xml 184 185 180 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 186 187 182 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 184 188 180 184 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>D</italic>-<italic>F</italic>:</bold>
###xml 453 456 449 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G-I</italic>
###xml 453 456 449 452 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G-I</italic></bold>
A-C: Backbone Calpha-traces of ABCB1 model (A), ABCC4 model (B) and ABCC5 model (C) viewed from intracellular side. Colour coding: blue via white to red from N-terminal to C-terminal. D-F: The water-accessible surfaces of ABCB1 model (D), ABCC4 model (E) and ABCC5 model (F) viewed from intracellular side collared coded according to the electrostatic potentials 1.4 A outside the surface; negative (-10 kcal/mol), red to positive (+10 kcal/mol), blue. G-I: Cross sections along the inner membrane layer of water-accessible surfaces of ABCB1 model (G), ABCC4 model (H) and ABCC5 model (I) viewed from intracellular side, colour coding as D-F. All illustrations are in similar view.
###end p 31
###begin p 32
###xml 8 12 8 12 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A-I</xref>
Figures 4A-I show the EPS of the substrate recognition area of each of the ABC models. The EPS of the substrate recognition area in the TMDs of ABCB1 was neutral with negative and weakly positive areas, while the EPS of the ABCC5 substrate recognition area was generally positive. The substrate recognition area of ABCC4 was generally positive with negative area "spots".
###end p 32
###begin p 33
###xml 104 105 104 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
The results from the stereochemical validations retrieved from the SAVES Metaserver  are shown in Table 1. Overall factors from the Errat option at ~90 indicate that the models were of high quality.
###end p 33
###begin p 34
Results from the stereochemical validations retrieved from the SAVES Metaserver
###end p 34
###begin p 35
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 410 423 410 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 453 454 453 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 605 618 597 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 625 627 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 713 714 705 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 410 422 <span type="species:ncbi:10090">Mus musculus</span>
###xml 548 553 <span type="species:ncbi:9606">human</span>
###xml 605 617 <span type="species:ncbi:10090">Mus musculus</span>
Site directed mutagenesis studies on ABCB1 have indicated that Ile306 (TMH5) [27,35], Ile340 (TMH6) [33], Phe343 (TMH6) [21,27], Phe728 (TMH7) [27], and Val982 (TMH12) [33,35] may participate in ligand binding. As shown in Figure 5A, these residues may form a substrate recognition site in the ABCB1 model. The involvement of these residues in ligand binding is confirmed in the X-ray crystal structure of the Mus musculus ABCB1 [20] (Figure 5B). Table 2 shows the corresponding residues in ABCC4 and ABCC5. Measured Calpha-Calpha distances in the human ABCB1 model, in the X-ray crystal structure of the Mus musculus ABCB1 [20] and experimental distance ranges from cross-linking studies and are listed in Table 3.
###end p 35
###begin p 36
###xml 0 143 0 143 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Comparison of proposed drug binding site in ABCB1 model (A) and the drug binding site in the X-ray crystal structure of P-glycoprotein (ABCB1) </bold>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 147 396 147 396 <bold xmlns:xlink="http://www.w3.org/1999/xlink"> (B) viewed from the intracellular side with amino acids suggested from site directed mutagenesis studies to take part in ligand binding displayed as sticks coloured according to atom type (C = grey; H = dark grey; O = red; N = blue); Ile306 (TMH5) </bold>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 403 419 403 419 <bold xmlns:xlink="http://www.w3.org/1999/xlink">, Ile340 (TMH6) </bold>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 423 439 423 439 <bold xmlns:xlink="http://www.w3.org/1999/xlink">, Phe343 (TMH6) </bold>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 446 462 446 462 <bold xmlns:xlink="http://www.w3.org/1999/xlink">, Phe728 (TMH7) </bold>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 466 487 466 487 <bold xmlns:xlink="http://www.w3.org/1999/xlink">, and Val982 (TMH12) </bold>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 558 571 558 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 545 550 <span type="species:ncbi:9606">human</span>
###xml 558 570 <span type="species:ncbi:10090">Mus musculus</span>
Comparison of proposed drug binding site in ABCB1 model (A) and the drug binding site in the X-ray crystal structure of P-glycoprotein (ABCB1) [20] (B) viewed from the intracellular side with amino acids suggested from site directed mutagenesis studies to take part in ligand binding displayed as sticks coloured according to atom type (C = grey; H = dark grey; O = red; N = blue); Ile306 (TMH5) [27,35], Ile340 (TMH6) [33], Phe343 (TMH6) [21,27], Phe728 (TMH7) [27], and Val982 (TMH12) [33,35]. Amino acids in panel B are numbered according to human ABCB1. Mus musculus numbering: Ile302, Ile336, Phe339 Phe724 and Val978. Differences in helix tilting in the panels refer to the different conformations of ABCB1, outward facing conformation in the left panel and closed conformation in the right panel.
###end p 36
###begin p 37
###xml 115 128 115 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 115 127 <span type="species:ncbi:10090">Mus musculus</span>
Human ABCB1 amino acid residues shown to interact with ligands in site directed mutagenesis studies, corresponding Mus musculus ABCB1 amino acids shown to interact with ligand in X-ray crystal structure [20], and corresponding amino acid residues in ABCC4 and ABCC5.
###end p 37
###begin p 38
###xml 37 50 37 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 37 49 <span type="species:ncbi:10090">Mus musculus</span>
*) Not direct contact with ligand in Mus musculus ABCB1 X-ray crystal structure [20].
###end p 38
###begin p 39
###xml 95 108 79 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 139 141 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 95 107 <span type="species:ncbi:10090">Mus musculus</span>
Comparison of Calpha-Calpha distances in the human ABCB1 model, Calpha-Calpha distances in the Mus musculus ABCB1 X-ray crystal structure [20] and distances between residues from experimental cross-linking studies on ABCB1.
###end p 39
###begin p 40
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
Values from experimental cross-linking studies are derived from [41].
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 567 584 567 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1038 1040 1038 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1295 1297 1291 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1543 1560 1539 1556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 454 459 <span type="species:ncbi:9606">human</span>
###xml 567 583 <span type="species:ncbi:562">Escherichia coli</span>
###xml 1543 1559 <span type="species:ncbi:562">Escherichia coli</span>
Visualization of the molecular structures of human ABC transporters in 3D models contributes to the comprehension of the physical and chemical properties of these molecules, and of their intermolecular interactions with endogenous and exogenous molecules. Thus, interactions involved in determining the potencies and the specificities of different drugs with these drug targets can be identified. To construct a realistic molecular model ("target", e.g. human ABC transporters) by homology, based on an experimental structure ("template", e.g. the open inward facing Escherichia coli MsbA [19]), the sequence identity between the target and the template should be relatively high, and the target-template alignment should identify corresponding positions in the target and the template. Homology between two proteins indicates the presence of a common ancestor, and phylogenetic analyses of ABC transporters have indicated that eukaryotic ABCB transporters and ABCC transporters may have originated from bacterial multidrug transporters [47]. It has been shown that the homology modelling approach is at least as applicable to membrane proteins as it is to water-soluble proteins, and that sequence similarities of 30% between template and target will give a Calpha-RMSD of 2 A or less in TMHs [48]. The sequence identities between the template molecule MsbA and the target molecules ABCB1, ABCC4 and ABCC5 are 34%, 21% and 25%, respectively, and the secondary structure elements (NBDs and TMDs) are conserved. Sequence identities between the Escherichia coli MsbA TMD and the ABCB1, ABCC4 and ABCC5 TMD1s and TMD2s are 23% (ABCB1-TMD1), 21% (ABCB1-TMD2), 14% (ABCC4-TMD1), 18% (ABCC4-TMD2), 20% (ABCC5-TMD1) and 20% (ABCC5-TMD2), respectively.
###end p 42
###begin p 43
###xml 30 32 30 32 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 338 355 338 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 526 543 526 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 646 659 646 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 666 668 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 866 868 866 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 322 327 <span type="species:ncbi:9606">human</span>
###xml 338 354 <span type="species:ncbi:562">Escherichia coli</span>
###xml 510 515 <span type="species:ncbi:9606">human</span>
###xml 526 542 <span type="species:ncbi:562">Escherichia coli</span>
###xml 646 658 <span type="species:ncbi:10090">Mus musculus</span>
A multiple sequence T-COFFEE [38] alignment, which highlights evolutionary relationships and increases probability that corresponding sequence positions are correctly aligned, was used to create the target-template alignments in this study. The T-COFFEE [38] alignment differed from the previously published alignments of human ABCB1 and Escherichia coli MsbA [19,41] in TMH2 and TMH6. The ABCB1 model based on the combined alignment, with TMH2 adjusted corresponding to the previously published alignments of human ABCB1 and Escherichia coli MsbA [19,41], was in the best agreement with cross-linking data and the X-ray crystal structure of the Mus musculus ABCB1 [20]. This illustrates that combining different alignment methods may strengthen the alignment used for homology modelling. The alignment correctly aligning TMH2 was created using ClustalW and HMMTOP [41], while T-COFFEE, which aligned TMH6 correctly, is broadly based on progressive approach to multiple alignment using a combination of local (Lalign) and global (ClustalW) pair-wise alignments to generate a library of alignment information which is used to guide the progressive alignment.
###end p 43
###begin p 44
###xml 35 48 35 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 55 57 55 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 248 249 248 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 366 379 366 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 604 606 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 778 791 778 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 798 800 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 892 905 892 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 912 914 912 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 35 47 <span type="species:ncbi:10090">Mus musculus</span>
###xml 366 378 <span type="species:ncbi:10090">Mus musculus</span>
###xml 778 790 <span type="species:ncbi:10090">Mus musculus</span>
###xml 892 904 <span type="species:ncbi:10090">Mus musculus</span>
The X-ray crystal structure of the Mus musculus ABCB1 [20] and site directed mutagenesis studies on ABCB1 may serve as validity tests both for helix orientation in the template [19], and for the alignment used for ABC transporter modelling (Figure 2). The helix orientation of the 12 TMHs of the ABCB1 model was in accordance with the X-ray crystal structure of the Mus musculus ABCB1 [20]. Both the ABCB1 model and the ABCB1 X-ray structure exhibited a V-shaped structure with the same relative domain orientations; TMDs twisted relative to the NBDs with TMH4 and TMH5 crossed over ("cross-over motif" [19]) and associated with TMD2, and TMH10 and TMH11 crossed over and associated with TMD1. The major difference between the ABCB1 model and the X-ray crystal structure of the Mus musculus ABCB1 [20] was that the V-shape of the ABCB1 model was wider than the X-ray crystal structure of the Mus musculus ABCB1 [20].
###end p 44
###begin p 45
###xml 81 94 65 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 125 127 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 247 248 231 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 373 386 341 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 417 419 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 653 666 621 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 697 699 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 821 834 789 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 865 867 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 955 968 923 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 999 1001 967 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1250 1263 1218 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 1294 1296 1262 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 31 36 <span type="species:ncbi:9606">human</span>
###xml 81 93 <span type="species:ncbi:10090">Mus musculus</span>
###xml 308 313 <span type="species:ncbi:9606">human</span>
###xml 373 385 <span type="species:ncbi:10090">Mus musculus</span>
###xml 546 551 <span type="species:ncbi:9606">human</span>
###xml 623 628 <span type="species:ncbi:9606">human</span>
###xml 653 665 <span type="species:ncbi:10090">Mus musculus</span>
###xml 791 796 <span type="species:ncbi:9606">human</span>
###xml 821 833 <span type="species:ncbi:10090">Mus musculus</span>
###xml 929 934 <span type="species:ncbi:9606">human</span>
###xml 955 967 <span type="species:ncbi:10090">Mus musculus</span>
###xml 1224 1229 <span type="species:ncbi:9606">human</span>
###xml 1250 1262 <span type="species:ncbi:10090">Mus musculus</span>
Calpha-Calpha distances in the human ABCB1 model, Calpha-Calpha distances in the Mus musculus ABCB1 X-ray crystal structure [20], and distances between residues in the TMD area from experimental cross-linking studies on ABCB1, are listed in Table 3. As shown in the table, the Calpha-Calpha distances in the human ABCB1 model compared to the Calpha-Calpha distances in the Mus musculus ABCB1 X-ray crystal structure [20] revealed that the helix packing of TMH pairs 2 and 11, 5 and 11, 6 and 7, and 6 and 11, were only 1-2 A further apart in the human ABCB1 model. TMHs 5 and 8 were packed approximately 1 A tighter in the human ABCB1 model than in the Mus musculus ABCB1 X-ray crystal structure [20]. TMH pairs 1 and 11, 4 and 10, and 5 and 10 were approximately 3-7 A further apart in the human ABCB1 model than in the Mus musculus ABCB1 X-ray crystal structure [20]. The most striking differences between helix packing of the human ABCB1 model and the Mus musculus ABCB1 X-ray crystal structure [20] were observed in TMHs 6 and 12. Whereas the differences of their packing towards other TMHs where in the range of 1-5 A towards the extracellular side, the differences between the distances between these TMHs long in the human ABCB1 model and the Mus musculus ABCB1 X-ray crystal structure [20] were up to 15 A towards the cytoplasm. This indicates that in order for ABCB1 to attain a wide open inward facing conformation, large conformational changes involving a scissors like movement of TMH6 and TMH12 may take place.
###end p 45
###begin p 46
###xml 19 21 19 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 38 40 38 40 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 41 43 41 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 61 63 61 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 84 86 84 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 295 308 295 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 353 366 353 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 534 535 534 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 842 844 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1064 1066 1064 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 295 307 <span type="species:ncbi:10090">Mus musculus</span>
###xml 353 365 <span type="species:ncbi:10090">Mus musculus</span>
As shown in Figure 5A, Ile306 (TMH5) [27,35], Ile340 (TMH6) [33], Phe343 (TMH6) [21,27], Phe728 (TMH7) [27], and Val982 (TMH12) [33,35] may form a substrate recognition site in the ABCB1 model. The involvement of these amino acid residues is also confirmed by the X-ray crystal structure of the Mus musculus ABCB1 [20]. Interestingly, Ile306 (Ile302 in Mus musculus ABCB1) actually points slightly towards the membrane in the X-ray crystal structure, while it points directly towards the translocation pore in the ABCB1 model (Figure 5). This could be due to twisting of TMH5 upon changing conformation from at drug recognition conformation to a drug bound conformation. Cross-linking studies on ABCB1 has proposed that residue pairs Asn296-Gly774, Ile299-Phe770, Ile299-Gly774, and Gly300-Phe770 (TMH5 and TMH8, respectively), are adjacent [23]. These residues are in direct contact with each other in the ABCB1 model presented in this study. Furthermore, cross-linking studies has also shown that Val133 and Cys137 (TMH2) are close to Ala935 and Gly939 (TMH11) [24]. In the present ABCB1 model, these residues are adjacent. This also implies that the orientations of these residues in the models are correctly localized, and that the alignment used for the ICM homology modelling procedure is correct.
###end p 46
###begin p 47
###xml 18 19 18 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 408 421 392 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 452 454 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 740 753 724 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 784 786 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 408 420 <span type="species:ncbi:10090">Mus musculus</span>
###xml 714 719 <span type="species:ncbi:9606">human</span>
###xml 740 752 <span type="species:ncbi:10090">Mus musculus</span>
As shown in Table 3, the Calpha-Calpha distances in the human ABCB1 model of residues that connect residues on both sides of the wings are substantially longer than distances measured by chemical cross-linking. This may be due to drug-induced fit in the cross-linking experiments, which is not reflected in the present open inward ABCB1 model. Interestingly, the corresponding Calpha-Calpha distances in the Mus musculus ABCB1 X-ray crystal structure [20] are also longer than distances measured by chemical cross-linking. The shorter distances measured by chemical cross-linking may represent conformations of ABCB1 that are closed to the cytoplasmic side, with the wings tighter than in the conformations of the human ABCB1 model and the Mus musculus ABCB1 X-ray crystal structure [20].
###end p 47
###begin p 48
###xml 23 40 23 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 575 576 575 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 732 734 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 23 39 <span type="species:ncbi:562">Escherichia coli</span>
The open inward facing Escherichia coli MsbA template may represent a functional inward-facing conformation of the transporter, even though conformational disruption of the protein due to the presence of detergent molecules during crystallization cannot be excluded. According to the Errat option of the SAVES Metaserver for analyzing and validating protein structures, which indicated that the stereochemical qualities of the models were realistic, the stereochemical quality of the template was poorer than the stereochemical qualities of the ABC transporter models (Table 1). This difference in quality may be due to the modelling procedures; the ABC transporter models were energy minimized using the AMBER 8.0 program package [37], whereas the template was not.
###end p 48
###begin p 49
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 56 58 56 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 403 420 403 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 711 713 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 170 175 <span type="species:ncbi:9606">human</span>
###xml 387 392 <span type="species:ncbi:9606">human</span>
###xml 403 419 <span type="species:ncbi:562">Escherichia coli</span>
Several ABCB1 models have previously been published [49-52] based on an MsbA X-ray crystal structure that was subsequently retracted [53]. In 2009, 4 molecular models of human P-glycoprotein in two different catalytic states were published [41] based on X-ray crystal structures of the bacterial MsbA in different conformations [19]. These models are based on the previous alignments of human ABCB1 and Escherichia coli MsbA [19,41], and consequently, the orientation of their TMH6 differ from the orientation of TMH6 in the ABCB1 model presented in this study. The measured Calpha-Calpha distances in our present ABCB1 model are in accordance with the corresponding distances in their open inward ABCB1 model [41].
###end p 49
###begin p 50
###xml 571 572 571 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 573 574 573 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 607 608 607 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 757 758 757 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1156 1157 1156 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1158 1160 1158 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1196 1197 1196 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 1242 1243 1242 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 1322 1323 1322 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
From a pharmacological point of view, the EPS of the ligand recognition area in the wide open conformation of each of the ABC transporters is of particular interest, since it may elucidate substrate differences between these transporters. The template structure was constructed by fitting the X-ray structure of outward facing MsbA to the electron density map of inward facing MsbA. The template conformation may therefore have limitations that can affect the calculated EPS in some regions of the models. ABCB1 transports cationic amphiphilic and lipophilic substrates [5-8], and, as illustrated in Figure 4, the EPS of its ligand recognition area was neutral with negative and weakly positive areas. In contrast, ABCC4 and ABCC5 transport organic anions [9], and the EPS of the ABCC5 substrate recognition area was generally positive. Interestingly, the substrate recognition area of ABCC4 was generally positive with negative area "spots". This may raise reflections over differences in substrate selectivity between the anionic transporters ABCC4 and ABCC5, and support the reports of ABCC4 with preference for cAMP and ABCC5 with preference for cGMP [9,10]. The EPS of cAMP and cGMP (Figure 6) indicates that the surface of cGMP (Figure 6, panel B and D) has a larger region of negative EPS than that of cAMP (Figure 6, panel A and C). This may indicate that cGMP binds stronger to the surface of ABCC5 than cAMP, while negative area "spots" on the surface of ABCC4 may contribute to stronger binding to cAMP than to cGMP.
###end p 50
###begin p 51
###xml 0 131 0 131 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The surface of cAMP (panel A and C) and cGMP (panel B and D) colour coded according to electrostatic potentials outside the surface</bold>
The surface of cAMP (panel A and C) and cGMP (panel B and D) colour coded according to electrostatic potentials outside the surface. The surface of cAMP in panel C are flipped 180degrees along the y-axis relative to panel A, while the surface of cGMP in panel D are flipped 180degrees along the y-axis compared with panel B.
###end p 51
###begin p 52
###xml 53 66 53 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 212 225 212 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 634 647 634 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 678 680 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 53 65 <span type="species:ncbi:10090">Mus musculus</span>
###xml 202 207 <span type="species:ncbi:9606">human</span>
###xml 212 224 <span type="species:ncbi:10090">Mus musculus</span>
###xml 634 646 <span type="species:ncbi:10090">Mus musculus</span>
The residues of the binding site of the ligand bound Mus musculus ABCB1 X-ray crystal structure [20] and the respective binding site of all three models are shown in Table 2. While the binding sites of human and Mus musculus ABCB1 features lipophilic residues (Leucine, isoleucines, phenyl alanines, valine), ABCC4 has charged and polar residues and ABCC5 has polar residues. A positively charged residue in the binding site area of ABCC5, Lys448, also may take part in interaction with organic anions. The binding sites of the ABCB1, ABCC4 and ABCC5 models are wider and more accessible to the cytoplasm than the binding site of the Mus musculus ABCB1 X-ray crystal structure [20], reflecting their wide open-inward conformation.
###end p 52
###begin p 53
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 570 572 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 587 609 587 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus </italic>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 654 656 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 657 659 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 677 679 677 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 700 702 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 745 747 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 748 750 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1052 1053 1052 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1244 1246 1244 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1391 1393 1391 1393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 587 608 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Crystal structures of ABC transporters captured in different conformations have revealed that ABC transporter mechanism involves alternating access of substrate from the inward to the outward facing conformation, with subunit twisting and domain swapping [18-20]. The putative substrate recognition pocket in the ABCB1, ABCC4 and ABCC5 models in the wide open inward conformation presented in this study contains the same amino acid residues as the putative substrate releasing pocket in our previous outward-facing molecular models of ABCB1 [15], ABCC4 [16] and ABCC5 [17] based on the Staphylococcus aureus ABC transporter Sav1866 [18]; Ile306 (TMH5) [27,35], Ile340 (TMH6) [33], Phe343 (TMH6) [21,27], Phe728 (TMH7) [27], and Val982 (TMH12) [33,35]. This indicates that these residues contribute to a substrate translocation pore that changes conformation from a high affinity inward facing substrate recognition binding site to a low affinity outward facing substrate releasing pocket. Mutating the corresponding residues of ABCC4 and ABCC5 (Table 2) into the ABCB1 residues would be a valuable test of our models. The models indicate that these mutants may have substrate specificity more similar to that of wild type ABCB1. Leu65 (TMH1) [26], which is also suggested to take part in ligand binding, and is localized in the substrate releasing pocket in the outward facing ABCB1 model [15], is slightly distant from the core area of the ligand recognition site in the inward facing ABCB1 model. This amino acid may come into contact with the ligand upon conformational changes associated with ligand binding.
###end p 53
###begin p 54
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
The models presented in this study may represent a substrate recognition conformation, and from a structure aided drug design point of view, the specificity and affinity of ABC transporter substrate binding in this conformation is of particular interest. When performing docking studies, the structural flexibility of transporters, and the structural changes of the drug and the drug target adopting an energetically favourable complex (induced-fit), as has been demonstrated in a cysteine-scanning mutagenesis and oxidative cross-linking study of substrate-induced changes in ABCB1 [22], should be considered in order to predict how a designed drug will fit into the drug target.
###end p 54
###begin p 55
###xml 346 359 346 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 514 531 514 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 537 539 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 667 668 667 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 346 358 <span type="species:ncbi:10090">Mus musculus</span>
###xml 514 530 <span type="species:ncbi:562">Escherichia coli</span>
The ABCB1, ABCC4 and ABCC5 models presented in this study should be considered as working tools for generating hypotheses and designing further experimental studies related to ABC transporter structure and function, and their drug interactions. The binding site of the ABCB1 transporter model is in accordance with X-ray crystal structure of the Mus musculus ABCB1 [20] and site directed mutagenesis data and cross-linking studies on ABCB1 [21-35], indicating that the open inward-facing conformation structure of Escherichia coli MsbA [19] is a suitable template for homology modelling of ABCB1, ABCC4 and ABCC5. The corresponding residues in ABCC4 and ABCC5 (Table 2) are candidates for point mutations in site directed mutagenesis studies.
###end p 55
###begin p 56
Co-ordinates of the ABCB1, ABCC4 and ABCC5 models are available from the authors upon request.
###end p 56
###begin title 57
Competing interests
###end title 57
###begin p 58
The authors declare that they have no competing interests.
###end p 58
###begin title 59
Authors' contributions
###end title 59
###begin p 60
AWR carried out the molecular modelling studies (homology modelling and model refinement, and quality validation), created sequence alignments, and drafted the manuscript. IS participated in the design of the study, and contributed with bioinformatics advice and critical review of the manuscript. GS conceived of the study and participated in its design, contributed with biological advice and critical review of the manuscript. All authors read and approved the final manuscript.
###end p 60
###begin title 61
Acknowledgements
###end title 61
###begin p 62
###xml 116 133 116 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 116 132 <span type="species:ncbi:562">Escherichia coli</span>
We are grateful to Dr. Geoffrey Chang for providing us with the model of the open inward-facing conformation of the Escherichia coli MsbA X-ray crystal structure. This work was supported with grants from the Norwegian Cancer Society.
###end p 62
###begin article-title 63
A functional-phylogenetic classification system for transmembrane solute transporters
###end article-title 63
###begin article-title 64
Structural biology. The xyz of ABC transporters
###end article-title 64
###begin article-title 65
The motor domains of ABC-transporters - What can structures tell us?
###end article-title 65
###begin article-title 66
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human ATP-binding cassette (ABC) transporter superfamily
###end article-title 66
###begin article-title 67
ATP-dependent transport of amphiphilic cations across the hepatocyte canalicular membrane mediated by mdr1 P-glycoprotein
###end article-title 67
###begin article-title 68
Multiple recognition of various amphiphilic molecules by the multidrug resistance P-glycoprotein: molecular mechanisms and pharmacological consequences coming from functional interactions between various drugs
###end article-title 68
###begin article-title 69
Interactions between P-glycoprotein substrates and other cationic drugs at the hepatic excretory level
###end article-title 69
###begin article-title 70
Interaction of common azole antifungals with P glycoprotein
###end article-title 70
###begin article-title 71
Multidrug resistance-associated proteins 3, 4, and 5
###end article-title 71
###begin article-title 72
The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides
###end article-title 72
###begin article-title 73
Considerations in the design and development of transport inhibitors as adjuncts to drug therapy
###end article-title 73
###begin article-title 74
###xml 55 70 <span type="species:ncbi:10029">Chinese hamster</span>
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
###end article-title 74
###begin article-title 75
Role of MRP4 and MRP5 in biology and chemotherapy
###end article-title 75
###begin article-title 76
###xml 29 34 <span type="species:ncbi:9606">human</span>
Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development
###end article-title 76
###begin article-title 77
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 114 119 <span type="species:ncbi:9606">human</span>
Molecular model of the outward facing state of the human P-glycoprotein (ABCB1), and comparison to a model of the human MRP5 (ABCC5)
###end article-title 77
###begin article-title 78
###xml 51 56 <span type="species:ncbi:9606">human</span>
Molecular model of the outward facing state of the human multidrug resistance protein 4 (MRP4/ABCC4)
###end article-title 78
###begin article-title 79
A molecular model of a putative substrate releasing conformation of multidrug resistance protein 5 (MRP5)
###end article-title 79
###begin article-title 80
Structure of a bacterial multidrug ABC transporter
###end article-title 80
###begin article-title 81
Flexibility in the ABC transporter MsbA: Alternating access with a twist
###end article-title 81
###begin article-title 82
Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding
###end article-title 82
###begin article-title 83
###xml 69 74 <span type="species:ncbi:9606">human</span>
Methanethiosulfonate derivatives of rhodamine and verapamil activate human P-glycoprotein at different sites
###end article-title 83
###begin article-title 84
###xml 74 79 <span type="species:ncbi:9606">human</span>
Substrate-induced conformational changes in the transmembrane segments of human P-glycoprotein. Direct evidence for the substrate-induced fit mechanism for drug binding
###end article-title 84
###begin article-title 85
###xml 78 83 <span type="species:ncbi:9606">human</span>
Disulfide cross-linking analysis shows that transmembrane segments 5 and 8 of human P-glycoprotein are close together on the cytoplasmic side of the membrane
###end article-title 85
###begin article-title 86
###xml 107 112 <span type="species:ncbi:9606">human</span>
Val133 and Cys137 in transmembrane segment 2 are close to Arg935 and Gly939 in transmembrane segment 11 of human P-glycoprotein
###end article-title 86
###begin article-title 87
###xml 106 111 <span type="species:ncbi:9606">human</span>
ATP hydrolysis promotes interactions between the extracellular ends of transmembrane segments 1 and 11 of human multidrug resistance P-glycoprotein
###end article-title 87
###begin article-title 88
###xml 27 32 <span type="species:ncbi:9606">human</span>
Transmembrane segment 1 of human P-glycoprotein contributes to the drug-binding pocket
###end article-title 88
###begin article-title 89
###xml 27 32 <span type="species:ncbi:9606">human</span>
Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket
###end article-title 89
###begin article-title 90
###xml 82 87 <span type="species:ncbi:9606">human</span>
Nucleotide binding, ATP hydrolysis, and mutation of the catalytic carboxylates of human P-glycoprotein cause distinct conformational changes in the transmembrane segments
###end article-title 90
###begin article-title 91
###xml 35 40 <span type="species:ncbi:9606">human</span>
Drug-stimulated ATPase activity of human P-glycoprotein requires movement between transmembrane segments 6 and 12
###end article-title 91
###begin article-title 92
###xml 45 50 <span type="species:ncbi:9606">human</span>
The packing of the transmembrane segments of human multidrug resistance P-glycoprotein is revealed by disulfide cross-linking analysis
###end article-title 92
###begin article-title 93
###xml 38 43 <span type="species:ncbi:9606">human</span>
Defining the drug-binding site in the human multidrug resistance P-glycoprotein using a methanethiosulfonate analog of verapamil, MTS-verapamil
###end article-title 93
###begin article-title 94
###xml 57 62 <span type="species:ncbi:9606">human</span>
Determining the dimensions of the drug-binding domain of human P-glycoprotein using thiol cross-linking compounds as molecular rulers
###end article-title 94
###begin article-title 95
###xml 46 51 <span type="species:ncbi:9606">human</span>
Location of the rhodamine-binding site in the human multidrug resistance P-glycoprotein
###end article-title 95
###begin article-title 96
###xml 60 65 <span type="species:ncbi:9606">human</span>
Vanadate trapping of nucleotide at the ATP-binding sites of human multidrug resistance P-glycoprotein exposes different residues to the drug-binding site
###end article-title 96
###begin article-title 97
Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux
###end article-title 97
###begin article-title 98
ICM - a new method for protein modeling and design. Applications to docking and structure prediction from the distorted native comformation
###end article-title 98
###begin article-title 99
###xml 2 8 <span type="species:ncbi:13443">Coffee</span>
T-Coffee: A novel method for fast and accurate multiple sequence alignment
###end article-title 99
###begin article-title 100
The PredictProtein server
###end article-title 100
###begin article-title 101
The SWISS-PROT protein sequence data bank and its supplement TrEMBL in 1999
###end article-title 101
###begin article-title 102
###xml 20 25 <span type="species:ncbi:9606">human</span>
Molecular models of human P-glycoprotein in two different catalytic states
###end article-title 102
###begin article-title 103
The Protein Data Bank
###end article-title 103
###begin article-title 104
Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins
###end article-title 104
###begin article-title 105
PROCHECK: a program to check the stereochemical quality of protein structures
###end article-title 105
###begin article-title 106
Errors in protein structures
###end article-title 106
###begin article-title 107
Verification of protein structures: patterns of nonbonded atomic interactions
###end article-title 107
###begin article-title 108
The evolutionary repertoires of the eukaryotic-type ABC transporters in terms of the phylogeny of ATP-binding domains in eukaryotes and prokaryotes
###end article-title 108
###begin article-title 109
On the accuracy of homology modeling and sequence alignment methods applied to membrane proteins
###end article-title 109
###begin article-title 110
###xml 46 51 <span type="species:ncbi:9606">human</span>
Predicting the three-dimensional structure of human P-glycoprotein in absence of ATP by computational techniques embodying crosslinking data: Insight into the mechanism of ligand migration and binding sites
###end article-title 110
###begin article-title 111
A structural model for the open conformation of the mdr1 P-glycoprotein based on the MsbA crystal structure
###end article-title 111
###begin article-title 112
###xml 31 36 <span type="species:ncbi:9606">human</span>
An atomic detail model for the human ATP binding cassette transporter P-glycoprotein derived from disulfide cross-linking and homology modeling
###end article-title 112
###begin article-title 113
A new dimer interface for an ABC transporter
###end article-title 113
###begin article-title 114
Retraction
###end article-title 114
###begin article-title 115
###xml 49 54 <span type="species:ncbi:9606">human</span>
Evidence for a Sav1866-like architecture for the human multidrug transporter P-glycoprotein
###end article-title 115
###begin article-title 116
Processing mutations disrupt interactions between the nucleotide binding and transmembrane domains of P-glycoprotein and the cystic fibrosis transmembrane conductance regulator (CFTR)
###end article-title 116
###begin article-title 117
###xml 55 60 <span type="species:ncbi:9606">human</span>
The "LSGGQ" motif in each nucleotide-binding domain of human P-glycoprotein is adjacent to the opposing walker A sequence
###end article-title 117

